- Home
- ICLR vs MNDY Comparison
ICLR vs MNDY Comparison
Compare ICLR & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | MNDY |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | Ireland | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 7.4B |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ICLR | MNDY |
|---|---|---|
| Price | $185.83 | $157.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 24 |
| Target Price | $201.23 | ★ $279.33 |
| AVG Volume (30 Days) | 1.0M | ★ 1.7M |
| Earning Date | 10-22-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 192.87 |
| EPS | ★ 7.47 | 1.23 |
| Revenue | ★ $8,102,602,000.00 | $1,166,095,000.00 |
| Revenue This Year | N/A | $28.81 |
| Revenue Next Year | $0.76 | $21.57 |
| P/E Ratio | ★ $24.87 | $128.02 |
| Revenue Growth | N/A | ★ 28.62 |
| 52 Week Low | $125.10 | $141.20 |
| 52 Week High | $228.29 | $342.64 |
Technical Indicators
Market Signals| Indicator | ICLR | MNDY |
|---|---|---|
| Relative Strength Index (RSI) | 62.18 | 45.08 |
| Support Level | $174.13 | $147.00 |
| Resistance Level | $191.15 | $148.97 |
| Average True Range (ATR) | 8.46 | 6.84 |
| MACD | 2.87 | 1.90 |
| Stochastic Oscillator | 85.77 | 77.66 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About MNDY monday.com Ltd.
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.